Aubagne, February 15, 2018 - The Board of Directors of Sartorius Stedim Biotech S.A. (SSB) resolved at its most recent meeting to submit a proposal to the Annual General Shareholders' Meeting on April 3, 2018, to pay a dividend for fiscal 2017 of €0.46 per share. The previous year's dividend was €0.42. Under this proposal, the total profit distributed would rise by 9.5% from €38.7 million to €42.4 million.

Furthermore, the Board of Directors will propose to the Annual General Shareholders´ Meeting to ratify the cooptation of Dr. Lothar Kappich as Director of the company. In September 2017, Lothar Kappich replaced Professor Arnold Picot, who passed away on July 9, 2017. Kappich's directorship would last for one more year.

In addition, the Board of Directors will submit a proposal to approve the renewal of the appointments of Susan Dexter and Anne-Marie Graffin as Directors, each for a three-year term.

This press release contains statements about the future development of the Sartorius Stedim Biotech Group. We cannot guarantee that the content of these statements will actually apply because these statements are based upon assumptions and estimates that harbor certain risks und uncertainties.

Sartorius AG published this content on 15 February 2018 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 15 February 2018 16:35:06 UTC.

Original documenthttps://www.sartorius.de/sartoriusDE/de/EUR/company/press/company-press-releases?setCountry=DE-de&nid=8801599193187

Public permalinkhttp://www.publicnow.com/view/51DD11A6E38316B8D424BE8C2047530B736973F5